Screener
BridgeBio Pharma BBIO Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $14.4B.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's market capitalization?
- BridgeBio Pharma (BBIO) reported market capitalization of $14.4B in Q1 2026.
- How has BridgeBio Pharma's market capitalization changed year-over-year?
- BridgeBio Pharma's market capitalization increased by 119.0% year-over-year, from $6.57B to $14.4B.
- What is the long-term trend for BridgeBio Pharma's market capitalization?
- Over 5 years (2020 to 2025), BridgeBio Pharma's market capitalization has grown at a 7.1% compound annual growth rate (CAGR), from $10.47B to $14.74B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about BridgeBio Pharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude